Open AccessThe efficacy and safety of osimertinib in treating nonsmall cell lung cancer
Author(s) -
Jing Liu,
Xuemei Li,
Yi Shao,
Xiaohong Guo,
Jian He
Publication year - 2020
Publication title -
medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.59
H-Index - 148
eISSN - 1536-5964
pISSN - 0025-7974
DOI - 10.1097/md.0000000000021826
Subject(s) - osimertinib , medicine , oncology , hazard ratio , lung cancer , cochrane library , adverse effect , meta analysis , epidermal growth factor receptor , cancer , confidence interval , erlotinib